Hydroxychloroquine Intermediate
143-29-3
Pharmaceutical Grade
98%
SHANGHAI
25kg/as customer's requirment
2020-03-31
API,Intermediate
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
5,8,11,13,16,19-Hexaoxatricosane
Other Name:5,8,11,13,16,19-Hexaoxatricosane;Methane,bis[2-(2-butoxyethoxy)ethoxy]-;Bis[2-(2-butoxyethoxy)ethoxy]methane;Cryoflex;TP 90B;Butylcarbitol formal;Bis(butylcarbitol)formal;Sartomer 660;Morton TP 90B;Mazon 1651;SR 660;Rhenosin W 90B;NSC 7185;Hallstar TP 90B;1-[2-[2-[2-(2-Butoxyethoxy)ethoxymethoxy]ethoxy]ethoxy]butane
CAS No.:143-29-3
Molecular Formula:C17H36O6
InChIKeys:InChIKey=DKWHHTWSTXZKDW-UHFFFAOYSA-N
Molecular Weight:336.46414
Exact Mass:336.46
EC Number:205-598-9
UNII:L0Y73G495R
NSC Number:7185
DSSTox ID:DTXSID3027112
HScode:2901100000
Characteristics-
PSA:
55.4
XLogP3:2.64370
Appearance:Liquid
Density:1.0497 (rough estimate)
Boiling Point:392.93°C (rough estimate)
Flash Point:147.7ºC
Refractive Index:1.4800 (estimate)
Toxicity:Oral-rat LD50: 1746 mg/kg; Oral-Mouse LD50; 2700 mg/kg
Flammability characteristics:Flammable; burning produces irritating fumes
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product